RxDoctor Payments Data

Matthew Lynch, MD

Plastic and Reconstructive Surgery · East Windsor, NJNPI 1609834704

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,159 of the $1,370 with a category attached, or 84.6%. 14 manufacturers reported payments, led by AbbVie at 26.4% of the total. 2025 is the largest year on record at $451, 3.4 times the $132 reported in 2019. That places this record below the midpoint for plastic and reconstructive surgery clinicians in NJ, where the typical reported total is $1,513.

$1,370in general payments, 2019–2025

Across 36 payments — averaging $38.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$362
  • Integra Lifesciences Corporation$226
  • Dilon Technologies, Inc.$163
  • Sientra, Inc.$120
  • Davol Inc.$110
  • Mentor Worldwide LLC$104
  • plus $286 from 8 others

What the payments were for

  • Food & beverage$1,15985%
  • Other$21115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,370 in reported general payments places this provider in the 45th percentile of 93 plastic and reconstructive surgery providers in New Jersey.

See all plastic and reconstructive surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$32,459
Medicare patients
33
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil37$244
Mupirocin14$72
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$48

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in East Windsor

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →